Asset Management One Co. Ltd. Sells 1,336 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Asset Management One Co. Ltd. cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 57,599 shares of the company’s stock after selling 1,336 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Henry Schein were worth $4,381,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. McGlone Suttner Wealth Management Inc. bought a new position in shares of Henry Schein in the fourth quarter valued at $39,000. Baystate Wealth Management LLC lifted its stake in shares of Henry Schein by 2,500.0% in the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock valued at $39,000 after buying an additional 500 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of Henry Schein during the third quarter valued at about $46,000. Covestor Ltd lifted its position in shares of Henry Schein by 88.4% during the first quarter. Covestor Ltd now owns 861 shares of the company’s stock valued at $75,000 after purchasing an additional 404 shares in the last quarter. Finally, RVW Wealth LLC bought a new position in shares of Henry Schein during the third quarter valued at about $104,000. 96.62% of the stock is owned by institutional investors.

Insider Activity at Henry Schein

In related news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of recent analyst reports. Barrington Research raised their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, February 28th. Jefferies Financial Group raised their price target on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Piper Sandler raised their price target on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research report on Monday, February 26th. Evercore ISI raised their price target on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research report on Wednesday, February 28th. Finally, Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Henry Schein has an average rating of “Hold” and an average target price of $81.09.

Henry Schein Price Performance

HSIC opened at $71.81 on Friday. The company has a market capitalization of $9.23 billion, a price-to-earnings ratio of 22.80, a PEG ratio of 1.80 and a beta of 0.87. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The firm has a 50-day moving average price of $74.91 and a 200-day moving average price of $72.60. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $85.65.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). The business had revenue of $3.02 billion during the quarter, compared to analysts’ expectations of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. Henry Schein’s revenue for the quarter was down 10.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.21 EPS. Equities analysts expect that Henry Schein, Inc. will post 5.07 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.